A study in human postmortem samples demonstrated that the mir-4443 was significantly increased (5.503-fold) in pericardial-fluid-derived exosomes from acute myocardial infarction subjects compared to controls, identifying it as a potential biomarker for this condition [Kim et al. DOI:10.3390/ijms25179619]. In a separate study on human newborns, the mir-4443 was found to be downregulated at 0–6 hours and upregulated at 7 days in the plasma of infants with perinatal asphyxia, indicating its potential as a dynamic biomarker for this hypoxic condition [Lai et al. DOI:10.1016/j.pedneo.2024.05.002].